Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Bartels

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
The Lancet. Oncology|May 3, 2025
Chemotherapy-free neoadjuvant pembrolizumab combined with trastuzumab and pertuzumab in HER2-enriched early breast cancer (WSG-KEYRICHED-1): a single-arm, phase 2 trialSherko Kuemmel, Monika Graeser, Peter Schmid, et al.
JCO Precision Oncology|March 21, 2024
High Concordance of Different Assays in the Determination of Homologous Recombination Deficiency-Associated Genomic Instability in Ovarian CancerNicole Pfarr, Karin von Schwarzenberg, Dario Zocholl, et al.
JHEP Reports : Innovation in Hepatology|February 12, 2026
Clinical practice and implications of biomarker testing in biliary tract cancer: An observational studySabrina Welland, Ann-Kristin Zöller, Ilektra A Mavroeidi, et al.
The Journal of Pathology. Clinical Research|December 10, 2021
Inter-observer agreement for the histological diagnosis of invasive lobular breast carcinomaMatthias Christgen, Leonie Donata Kandt, Wiebke Antonopoulos, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2024
Benchmarking whole exome sequencing in the German network for personalized medicineMichael Menzel, Mihaela Martis-Thiele, Hannah Goldschmid, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
The Lancet. Oncology|May 3, 2025
Chemotherapy-free neoadjuvant pembrolizumab combined with trastuzumab and pertuzumab in HER2-enriched early breast cancer (WSG-KEYRICHED-1): a single-arm, phase 2 trialSherko Kuemmel, Monika Graeser, Peter Schmid, et al.
JCO Precision Oncology|March 21, 2024
High Concordance of Different Assays in the Determination of Homologous Recombination Deficiency-Associated Genomic Instability in Ovarian CancerNicole Pfarr, Karin von Schwarzenberg, Dario Zocholl, et al.
JHEP Reports : Innovation in Hepatology|February 12, 2026
Clinical practice and implications of biomarker testing in biliary tract cancer: An observational studySabrina Welland, Ann-Kristin Zöller, Ilektra A Mavroeidi, et al.
The Journal of Pathology. Clinical Research|December 10, 2021
Inter-observer agreement for the histological diagnosis of invasive lobular breast carcinomaMatthias Christgen, Leonie Donata Kandt, Wiebke Antonopoulos, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2024
Benchmarking whole exome sequencing in the German network for personalized medicineMichael Menzel, Mihaela Martis-Thiele, Hannah Goldschmid, et al.
Pageof 5